Kenneth Sall

2.5k total citations · 1 hit paper
41 papers, 1.8k citations indexed

About

Kenneth Sall is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kenneth Sall has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Ophthalmology, 17 papers in Public Health, Environmental and Occupational Health and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kenneth Sall's work include Glaucoma and retinal disorders (26 papers), Ocular Surface and Contact Lens (17 papers) and Intraocular Surgery and Lenses (9 papers). Kenneth Sall is often cited by papers focused on Glaucoma and retinal disorders (26 papers), Ocular Surface and Contact Lens (17 papers) and Intraocular Surgery and Lenses (9 papers). Kenneth Sall collaborates with scholars based in United States, United Kingdom and Belgium. Kenneth Sall's co-authors include Thomas K. Mundorf, Brenda L. Reis, Joseph Tauber, Aparna Raychaudhuri, Harvey Dubiner, Jodi Luchs, Paul Karpecki, Charles P. Semba, Edward J. Holland and Amir Shojaei and has published in prestigious journals such as Diabetes Care, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Kenneth Sall

41 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease11Reprint requests to: Linda Lewis, 575 Anton Blvd, Suite 900, Costa Mesa, CA 92626.

2000 690 citations Kenneth Sall, Thomas K. Mundorf et al. Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth Sall United States	20	1.3k	908	566	328	312	41	1.8k
Roger Vogel United States	18	397 0.3×	832 0.9×	409 0.7×	65 0.2×	63 0.2×	38	1.2k
Franz H. Grus Germany	18	547 0.4×	587 0.6×	358 0.6×	64 0.2×	35 0.1×	39	1.1k
Takaaki Inaba Japan	18	390 0.3×	233 0.3×	269 0.5×	80 0.2×	23 0.1×	29	906
Andrea Facskó Hungary	19	183 0.1×	402 0.4×	354 0.6×	11 0.0×	40 0.1×	70	1.1k
Azucena H Kakazu United States	13	236 0.2×	91 0.1×	245 0.4×	15 0.0×	13 0.0×	21	557
Nawajes Mandal United States	19	131 0.1×	292 0.3×	87 0.2×	15 0.0×	28 0.1×	61	909
J.L. Bellot Spain	10	117 0.1×	429 0.5×	321 0.6×	15 0.0×	15 0.0×	16	702
Yajuan Zheng China	15	76 0.1×	245 0.3×	101 0.2×	11 0.0×	16 0.1×	41	701
Bruce Bogart United States	15	146 0.1×	62 0.1×	81 0.1×	23 0.1×	13 0.0×	26	593
Roberto González-Salinas Mexico	14	94 0.1×	402 0.4×	251 0.4×	6 0.0×	9 0.0×	56	601

Countries citing papers authored by Kenneth Sall

Since Specialization

Citations

This map shows the geographic impact of Kenneth Sall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Sall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Sall more than expected).

Fields of papers citing papers by Kenneth Sall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Sall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Sall. The network helps show where Kenneth Sall may publish in the future.

Co-authorship network of co-authors of Kenneth Sall

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Sall. A scholar is included among the top collaborators of Kenneth Sall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Sall. Kenneth Sall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Terry, et al.. (2018). Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery. Clinical ophthalmology. Volume 13. 69–86. 29 indexed citations

Stacy, Rebecca C., Kenneth Huttner, James H. Peace, et al.. (2018). A Randomized, Controlled Phase I/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or Glaucoma. American Journal of Ophthalmology. 192. 113–123. 13 indexed citations

Chen, Michelle Y., Kenneth Sall, Michael Tepedino, et al.. (2018). Patient-reported Outcomes of Bimatoprost Ocular Ring in an Open-label Extension Study in Patients with Open-angle Glaucoma or Ocular Hypertension. 59(9). 1231–1231. 1 indexed citations

Dubiner, Harvey, et al.. (2017). Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies. Clinical ophthalmology. Volume 11. 669–681. 10 indexed citations

Brandt, James D., Harvey Dubiner, Kenneth Sall, et al.. (2017). Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring. Ophthalmology. 124(10). 1565–1566. 49 indexed citations

Goldstein, Michael H., Joseph R. Martel, Kenneth Sall, et al.. (2016). Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease. Eye & Contact Lens Science & Clinical Practice. 43(5). 287–296. 19 indexed citations

González, Victoria, Javier Moreno‐Montañés, Kenneth Sall, et al.. (2016). Results of Phase IIB SYLTAG clinical trial with bamosiran in patients with glaucoma. Investigative Ophthalmology & Visual Science. 57(12). 3023–3023. 11 indexed citations

Myers, Jonathan S., et al.. (2016). A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma. Journal of Ocular Pharmacology and Therapeutics. 32(8). 555–562. 42 indexed citations

Holland, Edward J., Jodi Luchs, Paul Karpecki, et al.. (2016). Lifitegrast for the Treatment of Dry Eye Disease. Ophthalmology. 124(1). 53–60. 151 indexed citations

10.

Brandt, James D., Kenneth Sall, Harvey Dubiner, et al.. (2016). Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert. Ophthalmology. 123(8). 1685–1694. 81 indexed citations

11.

Tauber, Joseph, Paul Karpecki, Robert Latkany, et al.. (2015). Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease. Ophthalmology. 122(12). 2423–2431. 149 indexed citations

12.

Myers, Jonathan S., et al.. (2013). A Randomized, Phase II Study of Trabodenoson (INO-8875) in Adults with Ocular Hypertension (OHT) or Primary Open-Angle Glaucoma (POAG). Investigative Ophthalmology & Visual Science. 54(15). 2621–2621. 7 indexed citations

13.

Katz, Grégory, Harvey Dubiner, John R. Samples, Steven D. Vold, & Kenneth Sall. (2013). Three-Month Randomized Trial of Fixed-Combination Brinzolamide, 1%, and Brimonidine, 0.2%. JAMA Ophthalmology. 131(6). 724–724. 34 indexed citations

14.

Faulkner, Robert, Najam A. Sharif, Kenneth Sall, et al.. (2010). Aqueous Humor Concentrations of Bimatoprost Free Acid, Bimatoprost and Travoprost Free Acid in Cataract Surgical Patients Administered Multiple Topical Ocular Doses of LUMIGAN ^® or TRAVATAN ^®. Journal of Ocular Pharmacology and Therapeutics. 26(2). 147–156. 29 indexed citations

15.

Lindstrom, Richard L., Stephen S. Lane, Andrew J. Cottingham, et al.. (2010). Conjunctival Concentrations of a New Ophthalmic Solution Formulation of Moxifloxacin 0.5% in Cataract Surgery Patients. Journal of Ocular Pharmacology and Therapeutics. 26(6). 591–595. 4 indexed citations

16.

Katz, Harold R., Samuel Masket, Stephen S. Lane, et al.. (2005). Absorption of Topical Moxifloxacin Ophthalmic Solution Into Human Aqueous Humor. Cornea. 24(8). 955–958. 50 indexed citations

17.

Katz, Harold R., Stephen S. Lane, Samuel Masket, et al.. (2004). Human Aqueous Humor Concentrations of Moxifloxacin Following Two Multiple–Dose Topical Ocular Dosing Regimens of Vigamox®.. Investigative Ophthalmology & Visual Science. 45(13). 4926–4926. 2 indexed citations

18.

Sall, Kenneth, et al.. (2000). Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease11Reprint requests to: Linda Lewis, 575 Anton Blvd, Suite 900, Costa Mesa, CA 92626.. Ophthalmology. 107(4). 631–639. 690 indexed citations breakdown →

19.

Sall, Kenneth, et al.. (2000). The Efficacy and Safety of Brinzolamide 1% Ophthalmic Suspension (Azopt®) as a Primary Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension. Survey of Ophthalmology. 44. S155–S162. 57 indexed citations

20.

Stewart, William C., Harvey Dubiner, Thomas K. Mundorf, et al.. (1999). Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma. American Journal of Ophthalmology. 127(2). 142–147. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact